VYNT实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (30 Dec 2023 @ 04:39):

Stats
今日成交量	19 116.00
平均成交量	17 863.00
市值	1.23M
EPS	$0 ( 2024-03-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0721
ATR14	$0.00900 (4.64%)

Insider Trading

Date	Person	Action	Amount	type
2021-11-09	Hansen Paul R.	Buy	6 783	Common Stock, $0.0001 par value
2023-01-17	Hansen Paul R.	Buy	4 032	Common Stock, $0.0001 par value
2023-01-17	Harris Geoffrey E.	Buy	5 712	Common Stock, $0.0001 par value
2023-01-17	Fletcher R John	Buy	4 368	Common Stock, $0.0001 par value
2023-01-17	Horobin Joanna	Buy	7 526	Common Stock, $0.0001 par value

INSIDER POWER
98.15
Last 98 transactions
Buy: 5 441 265 \| Sell: 193 337

音量相关性

長: -0.14 (neutral)

短: 0.17 (neutral)

Signal:(69.635) Neutral

Cancer Genetics Inc 相关性

10 最正相关
BOCH	0.893
SHSP	0.855

10 最负相关
TDAC	-0.958
GAINL	-0.9
APOP	-0.882
RMRM	-0.838
NTEC	-0.825
ISNS	-0.814
CMLF	-0.802

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Cancer Genetics Inc 相关性 - 货币/商品

0.26
( neutral )

0.32
( neutral )

0.00
( neutral )

0.13
( neutral )

-0.86
( strong negative )

-0.20
( neutral )

Cancer Genetics Inc 财务报表

Annual	2022
营收:	$666 000
毛利润:	$-342 000 (-51.35 %)
EPS:	$-3.87

FY	2022
营收:	$666 000
毛利润:	$-342 000 (-51.35 %)
EPS:	$-3.87

FY	2021
营收:	$1.15M
毛利润:	$-699 000 (-60.89 %)
EPS:	$-9.03

FY	2020
营收:	$867 000
毛利润:	$-234 000 (-26.99 %)
EPS:	$-1.492

Financial Reports:

No articles found.

Cancer Genetics Inc

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.